Problematic social media use linked to depression symptoms

Receiving therapy for problematic social media use can be effective in improving the mental wellbeing of people with depression, finds a new study by UCL researchers.

Bristol Myers bets on neuroscience surge with $14B Karuna cash acquisition

Bristol Myers Squibb will buy CNS drugmaker Karuna Therapeutics for cash in a deal valued at $14 billion, the companies announced Friday morning. The move

December 23, 2023

Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone

SAN FRANCISCO — Combining a PARP inhibitor with an androgen receptor pathway inhibitor as first-line therapy for biomarker-selected patients with metastatic castration-resistant prostate cancer (mCRPC)

January 27, 2024

Scientists have mapped the human brain in unprecedented detail. They’re just getting started

The brain remains both the body’s most important organ and its least understood. But a draft atlas of the human brain published on Thursday gives

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.